These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1334278)

  • 1. [Obesity: drugs].
    Héraïef E
    Rev Med Suisse Romande; 1992 Nov; 112(11):933-7. PubMed ID: 1334278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value and danger of drugs prescribed in obesity].
    Lumbroso P
    Therapeutique; 1971; 47(6):635-8. PubMed ID: 5571185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of obesity].
    Cairella M
    Clin Ter; 1978 Mar; 84(6):571-92. PubMed ID: 648107
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacotherapeutic possibilities in obesity].
    Opitz K
    Med Monatsschr; 1975 Dec; 29(12):530-4. PubMed ID: 1207648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug treatment of obesity].
    Héraïef E; Burckhardt P
    Ther Umsch; 1989 May; 46(5):309-18. PubMed ID: 2662470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rôle of anorectic agents and other drugs in treatment of obesity].
    Laurent LP
    Vie Med Can Fr; 1972 May; 1(5):491-3. PubMed ID: 4643642
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of obesity].
    Zara M
    Therapeutique; 1970 Dec; 46(10):1025-8. PubMed ID: 5511929
    [No Abstract]   [Full Text] [Related]  

  • 8. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 9. A treatment for refractory obesity using fenfluramine without dietary restriction.
    Sedgwick JP
    Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
    [No Abstract]   [Full Text] [Related]  

  • 10. New agent for obesity management.
    Barkin RL
    J Fam Pract; 1996 Sep; 43(3):224. PubMed ID: 8797740
    [No Abstract]   [Full Text] [Related]  

  • 11. New agent for obesity management.
    Clemenson ND
    J Fam Pract; 1996 Sep; 43(3):224; author reply 225. PubMed ID: 8797741
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug to treat obesity: editorial writer responds.
    Faich GA
    CMAJ; 1997 Apr; 156(7):978. PubMed ID: 9099162
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity--the health hazard of our time.
    Sedgwick JP
    S Afr Med J; 1971 Apr; 45(14):362-70. PubMed ID: 4930511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
    Ortensio A; Avagnina S; Costantino A
    Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 16. Appetite depressants: weights and measures.
    Hopkins SJ
    Nurs Mirror; 1981 Sep; 153(11):34-5. PubMed ID: 6912546
    [No Abstract]   [Full Text] [Related]  

  • 17. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 18. Fenfluramine in the treatment of obesity.
    Spence AW; Medvei VC
    Br J Clin Pract; 1966 Dec; 20(12):643-4. PubMed ID: 5974503
    [No Abstract]   [Full Text] [Related]  

  • 19. Dexfenfluramine.
    Spollett G
    Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953
    [No Abstract]   [Full Text] [Related]  

  • 20. The evaluation of a new appetite-reducing agent (Prefil) in the management of obesity.
    Valle-Jones JC
    Br J Clin Pract; 1980 Mar; 34(3):72-4. PubMed ID: 6246911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.